High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma.
about
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic toolsAllelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysisSpanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decadeLoss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck CancerFocal DNA copy number changes in neuroblastoma target MYCN regulated genesThe tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersMolecular pathogenesis of peripheral neuroblastic tumorsA constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genesHigh-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastomaThe role of complex genomic alterations in neuroblastoma risk estimation.Co-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastoma.A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemiaCopy number analysis identifies novel interactions between genomic loci in ovarian cancerMicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics.Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.Identification of common microRNA-mRNA regulatory biomodules in human epithelial cancers.Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease.Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility.Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene.Modeling Multiple Responses via Bootstrapping Margins with an Application to Genetic Association Testing.Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridizationDetection of DNA copy number alterations in cancer by array comparative genomic hybridization.Ultra-high resolution array painting facilitates breakpoint sequencing.Protein tyrosine phosphatases: functional inferences from mouse models and human diseases.High-content analysis of cancer genome DNA alterations.Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeLack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome.Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.Molecular characterization and classification of neuroblastoma.Protein tyrosine phosphatases in glioma biologyProgress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family.The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.New insights into the genetics of neuroblastoma.
P2860
Q21245700-D1922BCA-78CB-4F81-99C2-FB5424B0675FQ24632950-FD6BDA13-CA01-45CD-90F1-DA2768596D65Q24657188-FA8CE838-9D10-4B99-9B86-D5E5A38B689EQ26770333-A7AD4066-D021-4A83-B611-1826A0DB83F3Q27853197-4828C9EC-A855-48AE-BD56-6A9BDCD394DBQ28115604-AD00EBBC-1F16-4D94-8CC0-A7A3C886C085Q28115840-60AB7446-09B1-4592-9887-609AEBABCECDQ28271405-ABBE573A-7CC4-4DA4-9753-3528230B604EQ33336547-CB031E8D-C87A-4CAE-83A3-E04A14E93EE7Q33355806-4DA54BC3-1103-459D-B281-C74A82E6EBA6Q33891984-A4993C56-6F14-47A7-9825-BCBEE0F59DFDQ33918821-AC3445C8-9D6C-46E5-B3EF-749B5CEDAA73Q33952442-AD3F6E24-BE17-451A-ACB7-EC5FBA6D5576Q34065944-75B19456-5B2D-4F9C-BC61-9D529B2DCDCFQ34095608-DE966862-8E4F-4C74-9CF4-8C510E001E46Q34117394-DE1FDF53-4B1D-4810-B6C8-F9B24E65220EQ34155009-77C48173-079D-42A5-BE20-057B5D27F7CCQ34550261-8955E6DF-EEB7-4D46-A85C-EF67B7339B83Q34577943-2434526E-EF06-407D-AAB7-EA74F4E3518EQ35032621-013A9E88-5AE9-4A29-A264-6BDBB819B2F8Q35219060-86850595-066D-4188-80A4-A360E4B0530FQ35677257-0D1ECDD7-B8F0-468D-9CF9-0CD354CE961BQ35915024-AC2303BB-DA44-4160-9AFA-38BC6524A8B7Q36092374-D7509CB6-C816-4CD0-A797-0320F800FAD9Q36239745-565E5387-A06E-495C-9A8B-20F66E32CCADQ36357428-AC160993-40CB-4FB9-ADE6-D9321DD852B4Q36943634-F084D657-3AA4-41A3-A6AC-E1A7489DDB3FQ37004493-06D312B8-280F-45E8-85F5-3ED620A010CFQ37094061-E4E8C9D5-2D98-47EC-BABE-CCA3D0F95BD3Q37109744-A748C639-E670-4D7E-8E2D-DAC8597F822CQ37143660-7A563010-F60C-49D4-9C56-384A2BFF4120Q37222603-00BA91F9-53C8-4093-9414-D80DDD8207D7Q37377962-80BEE60B-AB2A-4FCF-93AD-D4DD58DE12F8Q37385138-A55A755F-0FB2-4A41-8F59-A525195CADECQ37515355-AD9F997A-D34D-416A-942A-8F427D066E05Q37638344-A81CA945-F52D-4D85-A686-22B361914C13Q37939996-8D4766F8-0E5A-488C-9703-85FB46A2380FQ37962577-703446EC-FABF-4266-9EAA-4E32AB01A7F7Q38070334-C691160C-3A34-4071-A649-9BA4C865A654Q38074875-11E6954D-4F6E-4013-8663-40D9A90DE506
P2860
High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
High-resolution analysis of ch ...... pressor gene in neuroblastoma.
@en
type
label
High-resolution analysis of ch ...... pressor gene in neuroblastoma.
@en
prefLabel
High-resolution analysis of ch ...... pressor gene in neuroblastoma.
@en
P2093
P1433
P1476
High-resolution analysis of ch ...... pressor gene in neuroblastoma.
@en
P2093
Anne O'Meara
Daniel Catchpoole
Fin Breatnach
John M Maris
Michael McDermott
Prakash Nair
Raymond L Stallings
P304
P356
10.1158/0008-5472.CAN-05-4154
P407
P577
2006-04-01T00:00:00Z